Legal status · United Kingdom
Is RLS-1496 legal in the United Kingdom?
No. RLS-1496 is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
RLS-1496 in the United Kingdom at a glance
| Classification | Investigational, not licensed |
|---|---|
| MHRA approval status | Not approved by MHRA; investigational |
| Evidence level | Preliminary (research strength: Preliminary) |
| Reviewed | Sep 2026 |
Classification and note come from the RLS-1496 profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
RLS-1496 is being studied in registered clinical trials but has not received MHRA marketing approval in the United Kingdom.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What RLS-1496 is
Rubedo's topical senolytic that met its Phase 1 safety endpoint in psoriasis, eczema and photo-aged skin, with collagen gene expression rising in treated skin.
RLS-1496 is designed to clear pathologic senescent skin cells by modulating glutathione peroxidase 4. In a Phase 1 reported in March 2026, it was well tolerated; a quarter of psoriasis and atopic dermatitis participants had a 4-point or greater drop in itch at four weeks versus none on vehicle, and photo-aged skin showed dose-dependent target engagement with increasing collagen gene expression.
Mechanism: Selective modulation of GPX4 in senescent cells, triggering their removal while sparing healthy cells.
Regulatory history: Investigational; Phase 1
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for RLS-1496 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
RLS-1496 in other countries
Frequently asked questions
Is RLS-1496 legal in the United Kingdom?
No. RLS-1496 is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
Can I buy RLS-1496 in the United Kingdom?
No approved product exists to buy. In the United Kingdom RLS-1496 is classified as "Investigational, not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is RLS-1496 MHRA approved?
No. In the United Kingdom RLS-1496 is classified as "Investigational, not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: Investigational; Phase 1. Evidence level: Preliminary.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for RLS-1496 live on its compound profile.
RLS-1496 profileThis page is general information about the regulatory status of RLS-1496 in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.